Results 191 to 200 of about 402,090 (258)
Some of the next articles are maybe not open access.
Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults.
Journal of the American Medical Association (JAMA), 2023This JAMA Insights Clinical Update discusses current recommendations regarding prevention of Pneumocystis pneumonia in patients who are immunocompromised.
Shiwei Zhou, S. Aitken
semanticscholar +1 more source
Pediatric Clinics of North America, 1958
Pneumocystis carinii pneumonia or interstitial plasma-cell pneumonia is a common infection in Europe, where it occurs endemically or in small institutional epidemics. It affects chiefly premature or otherwise debilitated infants with a peak incidence at the age from 6 weeks to 4 months, but the disease has also been encountered in three adults.1In this
R M, HOWARD, W H, SHELDON
openaire +4 more sources
Pneumocystis carinii pneumonia or interstitial plasma-cell pneumonia is a common infection in Europe, where it occurs endemically or in small institutional epidemics. It affects chiefly premature or otherwise debilitated infants with a peak incidence at the age from 6 weeks to 4 months, but the disease has also been encountered in three adults.1In this
R M, HOWARD, W H, SHELDON
openaire +4 more sources
Clinical Infectious Diseases, 2020
BACKGROUND In the era of prophylaxis, Pneumocystis pneumonia has become a late-onset opportunistic infection requiring indications for prolonged prophylaxis to be defined.
H. Kaminski +14 more
semanticscholar +1 more source
BACKGROUND In the era of prophylaxis, Pneumocystis pneumonia has become a late-onset opportunistic infection requiring indications for prolonged prophylaxis to be defined.
H. Kaminski +14 more
semanticscholar +1 more source
Seminars in Respiratory and Critical Care Medicine, 2011
Pneumocystis (carinii) jiroveci pneumonia can occur in immunocompromised individuals, especially hematopoietic stem and solid organ transplant recipients and those receiving immunosuppressive agents, and is the most common opportunistic infection in persons with advanced human immunodeficiency virus (HIV) infection. The Pneumocystis genus was initially
Shelley A, Gilroy, Nicholas J, Bennett
openaire +2 more sources
Pneumocystis (carinii) jiroveci pneumonia can occur in immunocompromised individuals, especially hematopoietic stem and solid organ transplant recipients and those receiving immunosuppressive agents, and is the most common opportunistic infection in persons with advanced human immunodeficiency virus (HIV) infection. The Pneumocystis genus was initially
Shelley A, Gilroy, Nicholas J, Bennett
openaire +2 more sources
Seminars in Respiratory and Critical Care Medicine, 2008
Pneumocystis is an opportunistic fungus that is a major cause of morbidity and mortality in immunocompromised hosts. Despite a decline in incidence with the advent of highly active antiretroviral therapy (HAART), Pneumocystis remains the most common opportunistic infection in patients with the acquired immunodeficiency syndrome (AIDS) and is an ...
Laurie C, D'Avignon +2 more
openaire +2 more sources
Pneumocystis is an opportunistic fungus that is a major cause of morbidity and mortality in immunocompromised hosts. Despite a decline in incidence with the advent of highly active antiretroviral therapy (HAART), Pneumocystis remains the most common opportunistic infection in patients with the acquired immunodeficiency syndrome (AIDS) and is an ...
Laurie C, D'Avignon +2 more
openaire +2 more sources
A cluster of cases of pneumocystis pneumonia identified by shotgun metagenomics approach.
Journal of Infection, 2019Pneumocystis pneumonia (PCP) is a major threat in immunocompromised patients with high mortality, and early rapid diagnose is critical in its recovery.
Yi Zhang +5 more
semanticscholar +1 more source